Sympathetic Overactivity in Post-traumatic Stress Disorder

Recruiting N/A Interventional Study
Post-traumatic Stress Disorder Prehypertension
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 65
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
120 (estimated)
Sponsor
Emory University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Post-traumatic stress disorder (PTSD) is a highly prevalent anxiety disorder that is associated with an increased risk of cardiovascular (CV) disease and hypertension. One potential mechanism is overactivation of the sympathetic nervous system (SNS), both at rest and particularly during stress. This study will evaluate whether 8 weeks of daily DGB therapy or transcutaneous vagus nerve stimulation …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * prehypertensive and normotensive veterans with PTSD, and prehypertensive and normotensive veterans without PTSD (controls) Exclusion Criteria: * heart or vascular disease * illicit drug use within the last 6 months * excessive alcohol use (\>2 drinks per day) * pregnancy * a…
Contacts

Deirdre Dixon, MS

404-321-6111

deirdre.dixon@emory.edu

CONTACT

Jeanie Park, MD

404-321-6111

CONTACT